Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045901 · ClinicalTrials.gov registry record · Phase 4
A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
A Phase 4 study, sponsored by Duchesnay.
- Terminated
- Registry status
- Phase 4
- Development phase
- 131
- Enrollment target
NCT02045901 is a Phase 4 study that was terminated before completion, run by Duchesnay. The registered enrollment target is 131 participants.
The verdict
NCT02045901, a Phase 4 study, was terminated before completion, sponsored by Duchesnay.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 131 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the efficacy of Diclegis for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Diclegis in pregnant adolescents aged 12 to 17 years with placebo by assessing differences in the severity and occurrence of maternal adverse events (AEs).
Interventions
- DRUG Placebo (Sugar Pill)
- DRUG Diclegis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02045901
The ClinicalTrials.gov registry entry for NCT02045901 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duchesnay, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo (Sugar Pill) is the first listed.
NCT02045901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02045901 about?
NCT02045901 is a clinical study titled "A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents". The primary objective of this study is to compare the efficacy of Diclegis for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Diclegis in pregnant adolescents aged 12...
What is the current status of trial NCT02045901?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 131 participants. The study started on 2014-02. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02045901?
The interventions under investigation include: Placebo (Sugar Pill) (DRUG), Diclegis (DRUG).
Who is sponsoring clinical trial NCT02045901?
This trial is sponsored by Duchesnay, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.